3004.90.92.50/Lidocaine 5% Patch Transdermal System/Canada

Lidocaine 5% Patch Transdermal System from Canada

Adhesive transdermal patch delivering 5% lidocaine for prolonged relief of post-herpetic neuralgia pain. HTS 3004.90.92.50 covers this form of local anesthetic put up for retail therapeutic use as specified in heading description.

Duty Rate — Canada → United States

100%

Rate breakdown

9903.04.60100%Pharmaceuticals Annex IV: patented pharma articles — 100% floor rate

9903.05.860%Universal product exemption (U.S. note 52(b))

9903.05.900%Articles already subject to Section 232 (steel/aluminum/copper + derivatives, autos + parts, wood, medium/heavy vehicles + parts, semiconductors, patented pharma) — U.S. note 52(f)

Calculate with your customs value Verify classification with AI

Import Tips

• Patches must specify delivery rate (mg/hr) to prove measured dosing for tariff purposes

• Include bioequivalence data if generic; branded may require NDC verification

• Watch adhesive composition; if ostomy appliance-like, Note 6(l) directs to 3006